194 related articles for article (PubMed ID: 30312027)
1. Hemostatic abnormalities in patients with Ehlers-Danlos syndrome.
Artoni A; Bassotti A; Abbattista M; Marinelli B; Lecchi A; Gianniello F; Clerici M; Bucciarelli P; La Marca S; Peyvandi F; Martinelli I
J Thromb Haemost; 2018 Dec; 16(12):2425-2431. PubMed ID: 30312027
[TBL] [Abstract][Full Text] [Related]
2. Vascular type Ehlers-Danlos syndrome is associated with platelet dysfunction and low vitamin D serum concentration.
Busch A; Hoffjan S; Bergmann F; Hartung B; Jung H; Hanel D; Tzschach A; Kadar J; von Kodolitsch Y; Germer CT; Trobisch H; Strasser E; Wildenauer R
Orphanet J Rare Dis; 2016 Aug; 11(1):111. PubMed ID: 27488172
[TBL] [Abstract][Full Text] [Related]
3. Platelet and coagulation studies in Ehlers-Danlos syndrome.
Anstey A; Mayne K; Winter M; Van de Pette J; Pope FM
Br J Dermatol; 1991 Aug; 125(2):155-63. PubMed ID: 1911298
[TBL] [Abstract][Full Text] [Related]
4. Characterization of bleeding symptoms in Ehlers-Danlos syndrome.
Kumskova M; Flora GD; Staber J; Lentz SR; Chauhan AK
J Thromb Haemost; 2023 Jul; 21(7):1824-1830. PubMed ID: 37179130
[TBL] [Abstract][Full Text] [Related]
5. Collagen and bleeding diathesis in Ehlers-Danlos syndrome.
Udén A
Scand J Haematol; 1982 May; 28(5):425-30. PubMed ID: 7123147
[TBL] [Abstract][Full Text] [Related]
6. An update on the new classification of Ehlers-Danlos syndrome and review of the causes of bleeding in this population.
Jesudas R; Chaudhury A; Laukaitis CM
Haemophilia; 2019 Jul; 25(4):558-566. PubMed ID: 31329366
[TBL] [Abstract][Full Text] [Related]
7. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
8. Bleeding in the heritable connective tissue disorders: mechanisms, diagnosis and treatment.
Malfait F; De Paepe A
Blood Rev; 2009 Sep; 23(5):191-7. PubMed ID: 19592142
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
[TBL] [Abstract][Full Text] [Related]
10. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders.
De Paepe A; Malfait F
Br J Haematol; 2004 Dec; 127(5):491-500. PubMed ID: 15566352
[TBL] [Abstract][Full Text] [Related]
11. Platelet defect in a case of Ehlers-Danlos syndrome.
Onel D; Ulutin SB; Ulutin ON
Acta Haematol; 1973 Oct; 50(4):238-44. PubMed ID: 4201749
[No Abstract] [Full Text] [Related]
12. Type IV Ehlers-Danlos syndrome with aspirin sensitivity. A family study.
Grenko RT; Burns SL; Golden EA; Byers PH; Bovill EG
Arch Pathol Lab Med; 1993 Oct; 117(10):989-92. PubMed ID: 8215841
[TBL] [Abstract][Full Text] [Related]
13. ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders.
Alhaj D; Hagedorn N; Cuntz F; Reschke M; Schuldes J; Ruthenberg J; Bakchoul T; Greinacher A; Holzhauer S
Eur J Haematol; 2024 Jul; 113(1):54-65. PubMed ID: 38549165
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.
Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D
Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185
[TBL] [Abstract][Full Text] [Related]
15. Ehlers-Danlos syndrome, clotting disorders and muscular dystrophy.
Bertin P; Treves R; Julia A; Gaillard S; Desproges-Gotteron R
Ann Rheum Dis; 1989 Nov; 48(11):953-6. PubMed ID: 2512864
[TBL] [Abstract][Full Text] [Related]
16. DDAVP therapy controls bleeding in Ehlers-Danlos syndrome.
Stine KC; Becton DL
J Pediatr Hematol Oncol; 1997; 19(2):156-8. PubMed ID: 9149748
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic abnormalities in Noonan syndrome.
Artoni A; Selicorni A; Passamonti SM; Lecchi A; Bucciarelli P; Cerutti M; Cianci P; Gianniello F; Martinelli I
Pediatrics; 2014 May; 133(5):e1299-304. PubMed ID: 24753526
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of multiple electrode aggregometry as a screening tool for bleeding disorders in a pediatric hospital.
Haas T; Cushing MM; Varga S; Gilloz S; Schmugge M
Platelets; 2019; 30(4):498-505. PubMed ID: 29787319
[TBL] [Abstract][Full Text] [Related]
19. Increased augmentation index in patients with Ehlers-Danlos syndrome.
Roeder M; Thiel S; Baumann F; Sievi NA; Rohrbach M; Kohler M; Gaisl T
BMC Cardiovasc Disord; 2020 Sep; 20(1):417. PubMed ID: 32933483
[TBL] [Abstract][Full Text] [Related]
20. A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet function.
Arneson MA; Hammerschmidt DE; Furcht LT; King RA
JAMA; 1980 Jul; 244(2):144-7. PubMed ID: 7382073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
